1. Zhou Y, Yang G, He H, Pan X, Peng W, Chai X: Association between admission time and in-hospital mortality in acute aortic dissection patients: A retrospective cohort study. Heart & lung : the journal of critical care 2020, 49(5):651-659.
2. Zhou Y, Yang G, He H, Pan X, Peng W, Chai X: Triglyceride/High-Density Lipoprotein Cholesterol Ratio Is Associated with In-Hospital Mortality in Acute Type B Aortic Dissection. BioMed research international 2020, 2020:5419846.
3. Yang G, Peng W, Zhao Q, Peng J, Xiang X, Chai X: Aortic dissection in women during the course of pregnancy or puerperium: a report of 11 cases in central south China. International journal of clinical and experimental medicine 2015, 8(7):11607-11612.
4. Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, Ehrlich MP, Trimarchi S, Braverman AC, Myrmel T et al: Insights From the International Registry of Acute Aortic Dissection: A 20-Year Experience of Collaborative Clinical Research. Circulation 2018, 137(17):1846-1860.
5. Wang Y, Tan X, Gao H, Yuan H, Hu R, Jia L, Zhu J, Sun L, Zhang H, Huang L et al: Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection. Circulation 2018, 137(3):259-269.
6. Takagi H, Hari Y, Nakashima K, Kuno T, Ando T: Matrix metalloproteinases and acute aortic dissection: Et Tu Brute? Interactive cardiovascular and thoracic surgery 2019.
7. Peng W, Peng Z, Chai X, Zhu Q, Yang G, Zhao Q, Zhou S: Potential biomarkers for early diagnosis of acute aortic dissection. Heart & lung : the journal of critical care 2015, 44(3):205-208.
8. Shimony A, Filion KB, Mottillo S, Dourian T, Eisenberg MJ: Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection. The American journal of cardiology 2011, 107(8):1227-1234.
9. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC: Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003, 107(19):2403-2405.
10. Kalay N, Cetinkaya Y, Ozdogru I: Ischemia-modified albumin and myocardial ischemia. Journal of the American College of Cardiology 2007, 49(24):2375; author reply 2376-2377.
11. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT: Ischemia-modified albumin in relation to exercise stress testing. Journal of the American College of Cardiology 2006, 48(12):2482-2484.
12. Knapik-Kordecka M, Piwowar A, Zurawska-Plaksej E, Warwas M: [Ischemia modified albumin--specific marker in cardiological diagnostics?]. Wiadomosci lekarskie 2008, 61(10-12):263-268.
13. Yang G, Zhou Y, He H, Pan X, Chai X: Ischemia-Modified Albumin, a Novel Predictive Marker of In-Hospital Mortality in Acute Aortic Dissection Patients. Front Physiol 2019, 10:1253.
14. Marx G, Chevion M: Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. The Biochemical journal 1986, 236(2):397-400.
15. Uygun M, Yilmaz S, Pekdemir M, Duman C, Gurbuz YS: The diagnostic value of ischemia-modified albumin in a rat model of acute mesenteric ischemia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2011, 18(4):355-359.
16. Cho DK, Choi JO, Kim SH, Choi J, Rhee I, Ki CS, Lee SC, Gwon HC: Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coronary artery disease 2007, 18(2):83-87.
17. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. The Journal of emergency medicine 2000, 19(4):311-315.
18. Alhashemi JA: Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction. The American journal of emergency medicine 2006, 24(2):149-155.
19. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF: Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006, 92(1):113-114.
20. Giannone FA, Domenicali M, Baldassarre M, Bartoletti M, Naldi M, Laggetta M, Bertucci C, Colecchia A, Viale P, Bernardi M et al: Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 2015, 35(11):2425-2432.
21. Das M, Cevik Y, Erel O, Corbacioglu SK: Ischemia-modified albumin levels in the prediction of acute critical neurological findings in carbon monoxide poisoning. The Kaohsiung journal of medical sciences 2016, 32(4):201-206.
22. Turedi S, Patan T, Gunduz A, Mentese A, Tekinbas C, Topbas M, Karahan SC, Yulug E, Turkmen S, Ucar U: Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study. The American journal of emergency medicine 2009, 27(6):635-640.
23. Bhakthavatsala Reddy C, Cyriac C, Desle HB: Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes. Indian heart journal 2014, 66(6):656-662.
24. Mentese A, Mentese U, Turedi S, Gunduz A, Karahan SC, Topbas M, Turan A, Patan T, Turkmen S, Okur G et al: Effect of deep vein thrombosis on ischaemia-modified albumin levels. Emergency medicine journal : EMJ 2008, 25(12):811-814.
25. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B: Ischemia-modified albumin levels in cerebrovascular accidents. The American journal of emergency medicine 2008, 26(8):874-878.